Zdrowie i gospodarka · 12/07/2018

FDA Releases Draft Guidance for Long-Term Follow-Up of Human Gene Therapy Products

The FDA is releasing a draft guidance document that provides recommendations for long-term follow-up studies of human gene therapy products to collect data on delayed adverse events, intended to supersede a 2006 guidance and supplement another draft guidance